rs13695

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001067.4(TOP2A):​c.*578G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.185 in 207,890 control chromosomes in the GnomAD database, including 4,636 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.18 ( 3183 hom., cov: 32)
Exomes 𝑓: 0.20 ( 1453 hom. )

Consequence

TOP2A
NM_001067.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.77

Publications

25 publications found
Variant links:
Genes affected
TOP2A (HGNC:11989): (DNA topoisomerase II alpha) This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, alpha, is localized to chromosome 17 and the beta gene is localized to chromosome 3. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia. [provided by RefSeq, Jul 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.261 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TOP2ANM_001067.4 linkc.*578G>A 3_prime_UTR_variant Exon 35 of 35 ENST00000423485.6 NP_001058.2
TOP2AXM_005257632.2 linkc.*578G>A 3_prime_UTR_variant Exon 35 of 35 XP_005257689.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TOP2AENST00000423485.6 linkc.*578G>A 3_prime_UTR_variant Exon 35 of 35 1 NM_001067.4 ENSP00000411532.1
TOP2AENST00000577541.1 linkc.*4-83G>A intron_variant Intron 1 of 1 2 ENSP00000464055.1

Frequencies

GnomAD3 genomes
AF:
0.180
AC:
27279
AN:
151946
Hom.:
3184
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0648
Gnomad AMI
AF:
0.184
Gnomad AMR
AF:
0.152
Gnomad ASJ
AF:
0.293
Gnomad EAS
AF:
0.00307
Gnomad SAS
AF:
0.110
Gnomad FIN
AF:
0.199
Gnomad MID
AF:
0.256
Gnomad NFE
AF:
0.264
Gnomad OTH
AF:
0.193
GnomAD4 exome
AF:
0.200
AC:
11181
AN:
55826
Hom.:
1453
Cov.:
0
AF XY:
0.201
AC XY:
5192
AN XY:
25780
show subpopulations
African (AFR)
AF:
0.0640
AC:
162
AN:
2532
American (AMR)
AF:
0.146
AC:
237
AN:
1628
Ashkenazi Jewish (ASJ)
AF:
0.270
AC:
965
AN:
3578
East Asian (EAS)
AF:
0.000236
AC:
2
AN:
8486
South Asian (SAS)
AF:
0.0796
AC:
39
AN:
490
European-Finnish (FIN)
AF:
0.210
AC:
101
AN:
480
Middle Eastern (MID)
AF:
0.214
AC:
69
AN:
322
European-Non Finnish (NFE)
AF:
0.255
AC:
8604
AN:
33696
Other (OTH)
AF:
0.217
AC:
1002
AN:
4614
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
413
826
1238
1651
2064
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.179
AC:
27270
AN:
152064
Hom.:
3183
Cov.:
32
AF XY:
0.173
AC XY:
12873
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.0646
AC:
2682
AN:
41498
American (AMR)
AF:
0.152
AC:
2325
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.293
AC:
1016
AN:
3470
East Asian (EAS)
AF:
0.00308
AC:
16
AN:
5192
South Asian (SAS)
AF:
0.109
AC:
526
AN:
4822
European-Finnish (FIN)
AF:
0.199
AC:
2098
AN:
10548
Middle Eastern (MID)
AF:
0.248
AC:
73
AN:
294
European-Non Finnish (NFE)
AF:
0.264
AC:
17962
AN:
67958
Other (OTH)
AF:
0.191
AC:
404
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1085
2169
3254
4338
5423
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
288
576
864
1152
1440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.229
Hom.:
13739
Bravo
AF:
0.172
Asia WGS
AF:
0.0660
AC:
229
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.47
DANN
Benign
0.46
PhyloP100
-1.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13695; hg19: chr17-38545193; API